We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$33.1B
AUM Growth
+$1.62B
Cap. Flow
+$885M
Cap. Flow %
2.67%
Top 10 Hldgs %
37%
Holding
1,568
New
69
Increased
691
Reduced
367
Closed
73

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$864M
2
BAC icon
Bank of America
BAC
+$84.7M
3
EW icon
Edwards Lifesciences
EW
+$69M
4
BABA icon
Alibaba
BABA
+$65.5M
5
AMD icon
Advanced Micro Devices
AMD
+$56.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$83.9M
2
TYL icon
Tyler Technologies
TYL
+$73.9M
3
CNM icon
Core & Main
CNM
+$73M
4
ITRI icon
Itron
ITRI
+$71.3M
5
UBER icon
Uber
UBER
+$70.5M

Sector Composition

Rank Sector Weight
1 Technology 36.91%
2 Healthcare 15.81%
3 Financials 12.06%
4 Communication Services 11.11%
5 Consumer Discretionary 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRNS icon
876
Varonis Systems
VRNS
$5.26B
$1.45M ﹤0.01%
44,200
+15,800
+56% +$663K
FHI icon
877
Federated Hermes
FHI
$4.74B
$1.44M ﹤0.01%
27,653
-8,400
-23% -$427K
CSW
878
CSW Industrials
CSW
$5.59B
$1.43M ﹤0.01%
4,869
MAC icon
879
Macerich
MAC
$6.99B
$1.43M ﹤0.01%
77,256
+8,000
+12% +$141K
SPSC icon
880
SPS Commerce
SPSC
$2.86B
$1.43M ﹤0.01%
16,000
+6,100
+62% +$566K
CNO icon
881
CNO Financial Group
CNO
$5.07B
$1.43M ﹤0.01%
33,555
ADMA icon
882
ADMA Biologics
ADMA
$2.11B
$1.42M ﹤0.01%
77,800
+12,200
+19% +$206K
HRL icon
883
Hormel Foods
HRL
$13.4B
$1.42M ﹤0.01%
59,800
-62,249
-51% -$1.45M
FELE icon
884
Franklin Electric
FELE
$4.68B
$1.42M ﹤0.01%
14,823
LSTR icon
885
Landstar System
LSTR
$6.4B
$1.42M ﹤0.01%
9,844
+200
+2% +$26.6K
EG icon
886
Everest Group
EG
$14B
$1.41M ﹤0.01%
4,168
+89
+2% +$29.4K
BRBR icon
887
BellRing Brands
BRBR
$1.28B
$1.41M ﹤0.01%
52,880
+18,500
+54% +$574K
TGTX icon
888
TG Therapeutics
TGTX
$7.34B
$1.41M ﹤0.01%
47,400
-100
-0.2% -$3.27K
CRSP icon
889
CRISPR Therapeutics
CRSP
$5.22B
$1.41M ﹤0.01%
26,900
+3,000
+13% +$180K
AMKR icon
890
Amkor Technology
AMKR
$14.3B
$1.41M ﹤0.01%
35,676
-7,400
-17% -$263K
PJT icon
891
PJT Partners
PJT
$4.57B
$1.4M ﹤0.01%
8,400
+2,800
+50% +$479K
QLYS icon
892
Qualys
QLYS
$6.78B
$1.4M ﹤0.01%
10,551
+1,200
+13% +$165K
KYMR icon
893
Kymera Therapeutics
KYMR
$9.51B
$1.4M ﹤0.01%
18,000
-3,700
-17% -$250K
MHK icon
894
Mohawk Industries
MHK
$9.42B
$1.4M ﹤0.01%
12,811
NUVL
895
DELISTED
Nuvalent
NUVL
$1.4M ﹤0.01%
13,900
PRM icon
896
Perimeter Solutions
PRM
$5.53B
$1.39M ﹤0.01%
+50,600
New +$1.28M
STWD icon
897
Starwood Property Trust
STWD
$6.05B
$1.39M ﹤0.01%
77,197
MORN icon
898
Morningstar
MORN
$7.76B
$1.39M ﹤0.01%
6,372
BILL icon
899
BILL Holdings
BILL
$5.11B
$1.38M ﹤0.01%
25,356
+900
+4% +$46.2K
UBSI icon
900
United Bankshares
UBSI
$6.68B
$1.38M ﹤0.01%
35,946

Similar funds

Handelsbanken Fonder's Q4 2025 Portfolio in Review

As of Q4 2025, Handelsbanken Fonder held 1,568 positions worth $33.1B, up 5.1% from $31.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Handelsbanken Fonder's Q4 2025 filing shows 69 new, 691 increased, 367 reduced and 73 closed positions. Its largest new stake was Fluence Energy: 857,654 shares worth $17M. The largest sale was Eli Lilly, an estimated $83.9M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Financials.

  • Handelsbanken Fonder's largest Q4 2025 buy was Fluence Energy: 857,654 shares worth $17M.
  • Handelsbanken Fonder added most to Amazon in Q4 2025, an estimated $864M increase.
  • Handelsbanken Fonder's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $83.9M.
  • Handelsbanken Fonder fully exited Kellanova in Q4 2025, selling an estimated $26M.
  • Handelsbanken Fonder's ten largest holdings make up 37% of its $33.1B portfolio in Q4 2025.
  • Handelsbanken Fonder opened 69 new positions and closed 73 in Q4 2025.
  • Handelsbanken Fonder's portfolio value rose 5.1% quarter-over-quarter to $33.1B.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.